The goal of the Animal Management and Transgenic Mouse Core is to provide transgenic and the indicated knockout animals bred into distinct genetic backgrounds to each of the three projects of this Program Project. Due to the extensive numbers of mice that are required for each project, and since some of the genotypes are shared across more than one project, in order to ensure optimal quality control, mouse identification and smooth flow of animals, the functions of breeding and genotyping of animals are best done within a core by a team dedicated to that function. Further, the ordering, receipt, entry into the database, and distribution of aged and young Fischer 344 from the NIA colonies will be managed by Core C. In Core C, this team will be led by Dr. Shi Fang Van, and co-lead by Dr. Thomas Martin of the Institute of Comparative Medicine. Dr. Van has extensive experience in the breeding and genotyping of transgenic mice. Mechanisms are in place in Core C to facilitate mouse breeding, weaning, tattooing, tail biopsy and Southern blotting/PCR to determine genotype. Multiple quality controls are in place to ensure consistency of the strains by Southern, Northern, Western blotting of representative mice per strain at specified intervals, along with activity assays as indicated. Dr. Martin has extensive experience in the care and use of mice and has designed a thorough description of the care and management of aged mouse in our colonies. Core C will serve each of the three projects during each of the five years of the Program Project.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG026467-05
Application #
8378067
Study Section
Special Emphasis Panel (ZAG1-ZIJ-6)
Project Start
Project End
2014-02-28
Budget Start
2012-04-01
Budget End
2013-02-28
Support Year
5
Fiscal Year
2012
Total Cost
$524,225
Indirect Cost
$206,693
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Thiagarajan, Devi; Vedantham, Srinivasan; Ananthakrishnan, Radha et al. (2016) Mechanisms of transcription factor acetylation and consequences in hearts. Biochim Biophys Acta 1862:2221-2231
Thiagarajan, Devi; Ananthakrishnan, Radha; Zhang, Jinghua et al. (2016) Aldose Reductase Acts as a Selective Derepressor of PPARγ and the Retinoic Acid Receptor. Cell Rep 15:181-96
Schmidt, Ann Marie (2015) Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease. Vascul Pharmacol 72:1-8
Zirpoli, Hylde; Abdillahi, Mariane; Quadri, Nosirudeen et al. (2015) Acute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusion. PLoS One 10:e0116274
Gao, Minghui; Monian, Prashant; Quadri, Nosirudeen et al. (2015) Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell 59:298-308
Schmidt, Ann Marie (2015) The growing problem of obesity: mechanisms, consequences, and therapeutic approaches. Arterioscler Thromb Vasc Biol 35:e19-23
Vedantham, Srinivasan; Thiagarajan, Devi; Ananthakrishnan, Radha et al. (2014) Aldose reductase drives hyperacetylation of Egr-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals. Diabetes 63:761-74
Schmidt, Ann Marie (2014) Recent highlights of ATVB: diabetes mellitus. Arterioscler Thromb Vasc Biol 34:954-8
Bao, Li; Taskin, Eylem; Foster, Monique et al. (2013) Alterations in ventricular K(ATP) channel properties during aging. Aging Cell 12:167-76
Abdillahi, Mariane; Ananthakrishnan, Radha; Vedantham, Srinivasan et al. (2012) Aldose reductase modulates cardiac glycogen synthase kinase-3ýý phosphorylation during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 303:H297-308

Showing the most recent 10 out of 24 publications